H.R. 1518 · 119th Congress · Health
New Era of Preventing End-Stage Kidney Disease Act
A bill that started in the House. To become law it must pass the House and the Senate in identical form and be signed by the President.
Where it stands
In committee in the House
- Introduced — doneFeb 24, 2025
- Committee — not yet
- Passed the House — not yet
- Passed the Senate — not yet
- Sent to the President — not yet
- Became law — not yet
Latest action · Feb 24, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
What this bill means
In plain English
This bill establishes regional centers of excellence, postgraduate fellowships, and training for health professionals relating to the diagnosis and treatment of rare kidney disease. It also requires the Department of Health and Human Services (HHS) to conduct various studies on rare kidney disease.
From the official summary by the Congressional Research Service (introduced in house version). The full summary is below.
If it passes
It becomes federal law, and what it describes takes effect on the dates written into the bill.
What still has to happen
- 1A House committee must take it up and approve it. Most bills never get past this step.
- 2Then the full House must pass it.
- 3Then the Senate must pass it in the same form.
- 4Then it goes to the President to sign or veto.
If it doesn't pass
- Nothing changes. The law stays exactly as it is today — a bill has no effect unless it is enacted.
- This bill expires when the 119th Congress ends on Jan 3, 2027. To try again, a member would have to introduce it as a new bill in the next Congress and start over.
Read the full official summaryCongressional Research Service · Introduced in House · Feb 24, 2025
This bill establishes regional centers of excellence, postgraduate fellowships, and training for health professionals relating to the diagnosis and treatment of rare kidney disease. It also requires the Department of Health and Human Services (HHS) to conduct various studies on rare kidney disease.
Specifically, it authorizes the National Institute of Diabetes and Digestive and Kidney Diseases to award funding to public and private nonprofit entities for establishing regional centers of excellence that will increase public awareness, conduct research, and develop resources for diagnosing and treating rare kidney diseases. A center may receive such funding for up to five years, unless extended by the institute.
The bill also requires health professions schools receiving a grant from the Health Resources and Services Administration (HRSA) Centers of Excellence program to award fellowships for training on preventing, diagnosing, and treating rare kidney disease in disproportionately impacted populations.
Also, the bill expands the priorities of HRSA’s Primary Care Training and Enhancement program to include training for health care workers to care for individuals with kidney disease.
Additionally, HHS must conduct several studies and report to Congress on topics such as treating rare kidney disease in disproportionately affected populations, eliminating the need for dialysis or kidney transplants, and increasing public awareness of rare kidney disease.
Who started it
Sponsor — the member who introduced it

Introduced in the House on Feb 24, 2025.
See Gus M. Bilirakis's votes and donorsCosponsors — members who signed on in support
64cosponsors
45 Democrats · 19 Republicans
Members of both parties have signed on.
- Terri A. SewellD-AL-7
- Carol D. MillerR-WV-1
- Scott H. PetersD-CA-50
- Troy BaldersonR-OH-12
- Paul TonkoD-NY-20
- Bradley Scott SchneiderD-IL-10
- Danny K. DavisD-IL-7
- Ted LieuD-CA-36
Show all 64 cosponsorsHide the full list
- Neal P. DunnR-FL-2
- Brian K. FitzpatrickR-PA-1
- Dan CrenshawR-TX-2
- Eleanor Holmes NortonD-DC-0
- Thomas R. SuozziD-NY-3
- Julia BrownleyD-CA-26
- Jay ObernolteR-CA-23
- Michael LawlerR-NY-17
- Kathy CastorD-FL-14
- Donald G. DavisD-NC-1
- Joe WilsonR-SC-2
- Rashida TlaibD-MI-12
- Henry C. "Hank" JohnsonD-GA-4
- Patrick RyanD-NY-18
- Jerrold NadlerD-NY-12
- Andrew R. GarbarinoR-NY-2
- Sanford D. BishopD-GA-2
- J. Luis CorreaD-CA-46
- James P. McGovernD-MA-2
- Jonathan L. JacksonD-IL-1
- Jason CrowD-CO-6
- Darren SotoD-FL-9
- Zoe LofgrenD-CA-18
- Al GreenD-TX-9
- Deborah K. RossD-NC-2
- Robert MenendezD-NJ-8
- Sarah McBrideD-DE-0
- Young KimR-CA-40
- Alexandria Ocasio-CortezD-NY-14
- Eugene Simon VindmanD-VA-7
- Jefferson Van DrewR-NJ-2
- Glenn IveyD-MD-4
- Haley M. StevensD-MI-11
- Mike CareyR-OH-15
- Mike FloodR-NE-1
- Henry CuellarD-TX-28
- Gabe VasquezD-NM-2
- Jennifer A. KiggansR-VA-2
- Susie LeeD-NV-3
- Mike LevinD-CA-49
- Bennie G. ThompsonD-MS-2
- Judy ChuD-CA-28
- Yvette D. ClarkeD-NY-9
- Veronica EscobarD-TX-16
- Mark PocanD-WI-2
- Janelle S. BynumD-OR-5
- Mike ThompsonD-CA-4
- James R. WalkinshawD-VA-11
- Jack BergmanR-MI-1
- Abraham J. HamadehR-AZ-8
- William R. KeatingD-MA-9
- Don BaconR-NE-2
- Charles J. "Chuck" FleischmannR-TN-3
- Gwen MooreD-WI-4
- Chellie PingreeD-ME-1
- Christopher H. SmithR-NJ-4
Committees handling it
A bill is sent to the committee that covers its subject. The committee decides whether it ever reaches a vote of the full chamber.
Ways and Means Committee
House
- Referred To · Feb 24, 2025
Energy and Commerce Committee
House
- Referred To · Feb 24, 2025
Full timeline
Every recorded action on H.R. 1518, from the day it was introduced to the most recent, exactly as the House, the Senate, and the Library of Congress logged it.
- IntroducedHouse
Introduced in House
- House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Have a view on H.R. 1518? Your leaders vote on it.
Tell your senators and your representative where you stand. We fill in who represents you and reference this bill in the letter.
Write your leaders about thisSource: Congress.gov record for H.R. 1518(opens in new tab)